US Patent Issued to Black Diamond Therapeutics on Aug. 25 for "Method of treating cancers with alkyne substituted quinazoline derivatives" (American, Swiss Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,713, issued on Aug. 25, was assigned to Black Diamond Therapeutics Inc. (Cambridge, Mass.).

"Method of treating cancers with alkyne substituted quinazoline derivatives" was invented by Elizabeth Buck (Huntington, N.Y.), Matthew O'Connor (Massapequa Park, N.Y.), Darlene Romashko (Middle Island, N.Y.), Tai-An Lin (Jersey City, N.J.), Alexander Flohr (Basel, Switzerland), Luca Arista (Riehen, Switzerland), Iwona Wrona (Sharon, Mass.), Matthew Lucas (Lexington, Mass.), Chris Roberts (Belmont, Mass.), Giorgio Ottaviani (Riehen, Switzerland), Sherri Smith (South Boston, Mass.), Nigel Waters (Belmont, Mass.) and David M. Epstein (Belmont, Mass.).

According to the abstract* released by t...